Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Negative Valence Brain Targets and Predictors of Anxiety and Depression Treatment

NCT01903447 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.

NCT NCT01903447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01903447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Negative Valence Brain Targets and Predictors of Anxiety and Depression Treatment
Lead sponsor
University of Illinois at Chicago
Phase
Phase 4
Overall status
Completed
Start date
December 13, 2013
Completion date
February 21, 2018
Enrollment
271 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

internalizing psychopathologies (ips) depression and anxiety